Mesh Bio, MultiOmic partner to develop chronic metabolic disease medicines

Mesh Bio and MultiOmic Health will use artificial intelligence to develop precision medicines and diagnostics for chronic metabolic disease. Credit: Mesh Bio Pte. Ltd.